CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,142 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 6,882 shares (to pay taxes)
- 4 Open-market sale Director sold 4,083 shares at $3.33 ($13,596)
- 4 Option exercise Director acquired 11,667 shares (option exercise)
- 4 Shares withheld for taxes CFO gave up 12,555 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 8,545 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 10,764 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 20,045 shares (to pay taxes)
- 4 Open-market sale Director sold 2,000 shares at $4.27 ($8,540)
- 4 Option exercise Director acquired 4,274 shares (option exercise)
- 4 Open-market sale Director sold 961 shares at $5.01 ($4,815)
- 4 Open-market sale Chief Scientific Officer sold 10,317 shares at $9.15 ($94,401)
- 4 Open-market sale Chief Operating Officer sold 38,535 shares at $10.01 ($385,735)
- 4 Open-market sale Chief Scientific Officer sold 10,318 shares at $9.07 ($93,584)
- 4 Open-market sale CFO sold 33,750 shares at $10.01 ($337,838)
- 4 Open-market sale CFO sold 10,000 shares at $8.03 ($80,300)
- 4 Option exercise Director acquired 8,700 shares (option exercise)
- 4 Open-market sale Director sold 2,045 shares at $6.62 ($13,538)
- 4 Option exercise Director acquired 8,700 shares (option exercise)
- 4 Open-market sale Director sold 3,045 shares at $6.62 ($20,158)
Page 7 of 30 · 592 filings